Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine > News > Coffee may protect against prostate cancer
  • News

Coffee may protect against prostate cancer

  • 20 January 2021
  • Janet Fricker
Coffee may protect against prostate cancer
Total
0
Shares
0
0
0
0
0

Drinking several cups of coffee every day may be linked to a lower risk of developing prostate cancer. The meta-analysis study, published in BMJ Open, (11 January) found that each additional daily cup of coffee was associated with a 1% reduction in prostate cancer risk. However, the study should not be considered as giving men a freehand to drink limitless coffee as excessive caffeine consumption can cause negative health effects. A review,  suggests that a moderate consumption of 400mg/day caffeine poses no significant health risks.

Coffee represents one of the most widely consumed beverages in the world, containing many bioactive substances including antioxidants from the beans (including polyphenols and diterpenes) and antioxidants produced during the roasting process. In previous studies, coffee consumption has been linked to a lower relative risk of liver, bowel, and breast cancers. Inconsistent associations, however, have been found for the link between coffee intakes and risk of prostate cancer, with some studies not detecting any such associations and others suggesting lower risks of localised and advanced prostate cancer relating to increased intakes.

Since coffee is such a popular drink, the authors reason, even a small individual health effect might exert substantial overall public health benefits.

For the study, Kefeng Wang, (Shengjing Hospital of China Medical University, Liaoning, China), Wang and colleagues undertook a literature search identifying 16 prospective cohort studies evaluating the association of coffee consumption with the risk of prostate cancer. The studies, taking place in North America (n=7), Europe (n=7), and Japan (n=2), included 1,081,586 men, of whom 57,732 went on to develop prostate cancer. To measure coffee consumption, 11 studies used food-frequency questionnaires and five self-administered dietary questionnaires. Most studies adjusted for potential confounders, such as age, family history, race, cigarette smoking, alcohol consumption, and physical activity.Results of the pooled analysis showed that in comparison with the lowest category of coffee consumption, the highest category was associated with a reduction in prostate cancer of 9% (RR 0.91, 95%CI 0.84 to 0.98, I2=53.2%). The investigators further found that each additional daily cup was associated with a reduction in risk of 1% (pooled RR 0.988, 95%CI 0.981 to 0.995).

Exploring the different types of diagnosis, the investigators found that for localised prostate cancer the reduction was 7% (RR 0.93, 95%CI 0.87 to 0.99); for advanced prostate cancer 12% (RR 0.88, 95%CI 0.71 to 1.09); and for fatal prostate cancer 16% (RR 0.84, 95%CI 0.66 to 1.08).

Plausible biological mechanisms for the findings, highlighted by the authors, include coffee improving glucose metabolism, decreasing concentrations of plasma insulin and insulin-like growth factor-1, having anti-inflammatory and antioxidant effects, and influencing levels of sex hormones. The influence on sex hormones may relate to caffeine content. A nested case-control study  found that caffeinated coffee intakes were associated with increased sex hormone-binding globulin (SHBG) levels, but that the effect was not observed for decaffeinated coffee.

The findings, write the authors, need to be interpreted with caution since the amount of coffee consumed may have been misclassified as it depended on subject recall, and the type of coffee and brewing methods used varied between studies. Additionally, due to the observational design of the included cohort studies, unmeasured or uncontrolled factors in the original studies may have skewed pooled risk estimates. “If the association is further proved to be a causal effect, men might be encouraged to increase their coffee consumption to potentially decrease the risk of prostate cancer,” conclude the authors.

Carlo La Vecchia, Professor of Medical Statistics and Epidemiology at Università degli Studi di Milano, Italy, told Cancer World, “This study is an additional contribution that allows us to exclude any positive associations between coffee consumption and excess prostate cancer deaths. However, given the possibility of observational study bias errors, the suggestion higher intakes of coffee protect against prostate remains open to discussion.” One example of reverse causation, he adds, is the possibility that men with prostate cancer limit their coffee intake due to its pro diuretic effects.

Photo credits: Thomas Noonan

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • caffeine
  • prostate cancer
Janet Fricker

Janet Fricker is a medical writer specialising in oncology and cardiology. After researching articles for Cancerworld she runs, swims, and eats porridge.

Previous Article
  • News

Financial burden on older adults with advanced cancer worsens quality of life

  • 15 January 2021
  • Janet Fricker
View Post
Next Article
  • Patient’s Voices
  • Voices

From the New Yorker: What Cancer Takes Away

  • 22 January 2021
  • Anne Boyer
View Post
You May Also Like
View Post
  • Articles
  • News

CancerWorld issue #103 (May, 2025)

  • Yeva Margaryan
  • 11 May 2025
View Post
  • News

Personalised neoantigen vaccine for kidney cancer shows promise in phase 1 study

  • Janet Fricker
  • 8 May 2025
View Post
  • News
  • Senza categoria

What Caught Our Eye in April: Oncology’s Top Moments

  • Janet Fricker
  • 7 May 2025
View Post
  • News

CancerWorld #102 (April 2025)

  • Yeva Margaryan
  • 22 April 2025
View Post
  • News
  • Senza categoria

What Caught Our Eye in March: Oncology’s Top Moments

  • Janet Fricker
  • 8 April 2025
View Post
  • News

Ovarian cancer: mechanism conferring resistance to immunotherapy revealed

  • Janet Fricker
  • 21 March 2025
View Post
  • News

Muscular strength and cardiorespiratory fitness improve survival in cancer patients

  • Janet Fricker
  • 20 March 2025
View Post
  • News

CancerWorld #101 (February 2025): The Must-Read Oncology Issue Returns to Print with Exclusive Interviews and Breakthroughs

  • Yeva Margaryan
  • 18 March 2025
search
CancerWorld #101 Download CancerWorld #101 Download CancerWorld #101 Download or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • CancerWorld issue #103 (May, 2025)
    • 11 May 2025
  • Personalised neoantigen vaccine for kidney cancer shows promise in phase 1 study
    • 8 May 2025
  • What Caught Our Eye in April: Oncology’s Top Moments
    • 7 May 2025
  • CancerWorld #102 (April 2025)
    • 22 April 2025
  • What Caught Our Eye in March: Oncology’s Top Moments
    • 8 April 2025
Article
  • A Vision for Cancer Policy in Europe: An Interview with MEP Nikos Papandreou
    • 12 May 2025
  • (Re)Thinking Psycho-oncology in a world out of balance: What I learned after a year of interviews
    • 12 May 2025
  • CancerWorld issue #103 (May, 2025)
    • 11 May 2025
Social

Would you follow us ?

Contents
  • Adrian Gottschalk: Making a Difference for His Fellow Human Beings
    • 10 May 2025
  • ACT for Children:A Global Initiative to Tackle Inequities in Pediatric Cancer
    • 10 May 2025
  • Miriam Merad and the 2025 Sjöberg Prize: A Celebration of Innovation in Cancer Immunotherapy
    • 6 May 2025
MENU
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine
  • About us
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.) | Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States | [email protected]

Archivio Cancerworld

Input your search keywords and press Enter.